{"id":"CHEMBL10316","canonicalSmiles":"c1ccc2c(c1)OCC(C1=NCCN1)O2","inchiKey":"HPMRFMKYPGXPEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDAZOXAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Idazoxan","RX-781094"],"crossReferences":{"PubChem":["104171177","144203724","170466595","26751897","90341761"],"Wikipedia":["Idazoxan"],"drugbank":["DB12551"],"chEBI":["5862"]},"childChemblIds":["CHEMBL543467"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1078261","canonicalSmiles":"CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1","inchiKey":"QPCVHQBVMYCJOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPIVERINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Detrunorm","Detrunorm xl","Mictonorm"],"synonyms":["Propiverine","Propiverine hydrochloride"],"crossReferences":{"PubChem":["50125813"],"drugbank":["DB12278"],"chEBI":["8493"]},"childChemblIds":["CHEMBL2359059"],"count":3,"approvedIndications":["HP_0000020","HP_0000103"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for urinary incontinence and polyuria and has 1 investigational indication."}
{"id":"CHEMBL1094636","canonicalSmiles":"NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12","inchiKey":"PCHKPVIQAHNQLW-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIRAPARIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zejula"],"synonyms":["JNJ-64091742","MK-4827","MK4827","Niraparib","ZL-2306"],"crossReferences":{"DailyMed":["niraparib%20tosylate"],"drugbank":["DB11793"]},"childChemblIds":["CHEMBL3989922"],"count":31,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484"],"count":2},"linkedDiseases":{"rows":["EFO_1000412","EFO_0003869","EFO_0000365","EFO_0001075","MONDO_0007254","MONDO_0002087","EFO_0000305","MONDO_0001056","EFO_1000044","MONDO_0002158","MONDO_0008903","EFO_1000251","EFO_0000673","EFO_0008528","EFO_0000196","EFO_0000707","EFO_0002617","EFO_0002618","EFO_0000616","Orphanet_145","EFO_0009780","EFO_0006859","EFO_0003893","MONDO_0008170","EFO_1001512","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_0003863","EFO_0001061","EFO_1001100","EFO_0000095","EFO_0000174","EFO_0002517","MONDO_0011962","EFO_0000702","EFO_0000574","MONDO_0024880","EFO_0000519"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for cancer and neoplasm and has 29 investigational indications."}
{"id":"CHEMBL1159524","canonicalSmiles":"O=C(O)[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"AEMOLEFTQBMNLQ-QIUUJYRFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUCURONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03156"],"chEBI":["28860"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1190232","canonicalSmiles":"COc1ccc2nc3cc(Cl)ccc3c(NC(C)CCCN(CCCl)CCCl)c2c1","inchiKey":"UKOBAUFLOGFCMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1190232","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02240"],"chEBI":["37595"]},"childChemblIds":["CHEMBL3217099"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200421","drugType":"Small molecule","blackBoxWarning":false,"name":"TECHNETIUM TC 99M MEBROFENIN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110555","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Choletec","Technetium tc-99m mebrofenin"],"synonyms":["Technetium (99Mtc) Mebrofenin","Technetium (99mtc) mebrofenin","Technetium tc 99m mebrofenin","Technetium tc-99m mebrofenin kit"],"crossReferences":{"DailyMed":["technetium%20tc-99m%20mebrofenin%20kit"],"DrugCentral":["5119"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987 and has 1 investigational indication."}
{"id":"CHEMBL1200567","canonicalSmiles":"CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.O","inchiKey":"JRNIHERUNQWMMW-WBYAVNBMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXYCYCLINE HYCLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1433","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Alodox","Atridox","Doryx","Doxy 100","Doxy 200","Doxy-Caps","Doxy-Lemmon","Doxychel Hyclate","Doxycycline Hyclate","Periostat","Vibra-Tabs","Vibramycin","Vibramycin Hyclate"],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200629","canonicalSmiles":"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]","inchiKey":"VEPSYABRBFXYIB-PWXDFCLTSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"VECURONIUM BROMIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201219","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Musculax","Norcuron","Vecuronium bromide"],"synonyms":["ORG NC 45","ORG-NC 45","Pancuronium bromide impurity, vecuronium bromide -","Vecuronium bromide"],"crossReferences":{"DailyMed":["vecuronium%20bromide"],"PubChem":["144206024","170465295"],"chEBI":["9940"]},"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["EFO_0005323"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200665","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1.Cl","inchiKey":"SHTAFWKOISOCBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENOXYLATE HYDROCHLORIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201294","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diphenoxylate HCl","Diphenoxylate hydrochloride","Diphenoxylate hydrochloride cii","R-1132 (ANTIPERISTALTIC)"],"crossReferences":{"DailyMed":["diphenoxylate%20hydrochloride"],"PubChem":["144206146","144206378","170465332","49681550"],"chEBI":["59784"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1200682","canonicalSmiles":"O=C([O-])CCCO.[Na+]","inchiKey":"XYGBKMMCQDZQOZ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"SODIUM OXYBATE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1342","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xyrem"],"synonyms":[".gamma.-hydroxybutyrate sodium salt","NSC-84223","Oxybate sodium","Sodium oxybate","WY-3478"],"crossReferences":{"DailyMed":["sodium%20oxybate"],"DrugCentral":["4566"],"PubChem":["144206424"],"Wikipedia":["Sodium_oxybate"],"drugbank":["DB09072"]},"count":10,"approvedIndications":["MONDO_0021107","EFO_0000614"],"linkedTargets":{"rows":["ENSG00000136928","ENSG00000204681"],"count":2},"linkedDiseases":{"rows":["MONDO_0021107","EFO_0005203","EFO_0005687","HP_0001337","EFO_0004777","EFO_0002508","EFO_0000249","EFO_0004698","EFO_0003843","EFO_0000614","EFO_0003829","Orphanet_2131","Orphanet_93961","EFO_0003918","EFO_0003108","EFO_0004540","EFO_0007462"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for narcolepsy with cataplexy and narcolepsy and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201135","canonicalSmiles":"O=C(O)[C@H](O)[C@@H](O)C(=O)O.c1cnc2cc3c(cc2n1)C1CNCC3C1","inchiKey":"TWYFGYXQSYOKLK-LREBCSMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1201135","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1396","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207179"],"chEBI":["84507"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201391","canonicalSmiles":"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21","inchiKey":"XWLXKKNPFMNSFA-HGQWONQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENIVASTATIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tenivastatin"],"crossReferences":{"drugbank":["DB14714"]},"childChemblIds":["CHEMBL487720","CHEMBL2107785"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201467","drugType":"Small molecule","blackBoxWarning":true,"name":"SYNTHETIC CONJUGATED ESTROGENS, B","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Enjuvia"],"synonyms":["CE-10","Estrogens, conjugated synthetic b","Synthetic conjugated estrogens, b"],"crossReferences":{"DailyMed":["estrogens,%20conjugated%20synthetic%20b"]},"count":1,"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0003922"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2004 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201568","drugType":"Protein","blackBoxWarning":false,"name":"PEGFILGRASTIM","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neulasta","Neulasta sureclick"],"synonyms":["Granulocyte colony-stimulating factor pegfilgrastim","MYL-1401H","Pegfilgrastim","Pegfilgrastim for bioassay","TPI-120"],"crossReferences":{"DailyMed":["pegfilgrastim","pegfilgrastim-bmez","pegfilgrastim-cbqv","pegfilgrastim-jmdb"],"DrugCentral":["4986"],"Wikipedia":["Pegfilgrastim"]},"count":57,"approvedIndications":["MONDO_0001475"],"linkedTargets":{"rows":["ENSG00000119535"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000637","EFO_0003859","MONDO_0003890","EFO_0000756","EFO_0000681","EFO_0000571","EFO_1000231","EFO_1000657","EFO_0005952","EFO_1001951","EFO_0000565","EFO_1001952","MONDO_0002974","MONDO_0008903","EFO_0008528","EFO_0000514","Orphanet_654","EFO_0000198","EFO_0000220","EFO_0001642","MONDO_0008170","EFO_0002939","MONDO_0008315","EFO_1000238","EFO_0005537","EFO_0001359","EFO_0000233","EFO_0000574","EFO_0001378","MONDO_0009348","EFO_0000292","MONDO_0004192","EFO_0002913","MONDO_0007254","Orphanet_790","EFO_0004252","EFO_1001469","MONDO_0002087","HP_0001915","MONDO_0021063","EFO_0000305","MONDO_0020654","MONDO_0001187","MONDO_0001056","EFO_1001480","MONDO_0002158","MONDO_0001475","EFO_1001974","MONDO_0001657","EFO_0000183","MONDO_0002083","EFO_0000616","EFO_0006859","EFO_0000403","MONDO_0007576","EFO_0000222","EFO_1001953","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0006861","HP_0002653","EFO_0000702","MONDO_0018906","MONDO_0024880","EFO_0000691","EFO_0000181","MONDO_0004643"],"count":70},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for neutropenia and has 56 investigational indications."}
{"id":"CHEMBL1201576","drugType":"Antibody","blackBoxWarning":true,"name":"RITUXIMAB","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mabthera","Mabthera rituxan","Rituxan"],"synonyms":["ABP-798","CT-P10","HS-006","HS-006 (RITUXIMAB BIOSIMILAR)","HS006","IDEC-102","IDEC-C2B8","R-105 IDEC-102","RG-105","RHCACD20MA","Rituximab","Rituximab (genetical recombination)","SAIT-101","SAIT101"],"crossReferences":{"DailyMed":["rituximab","rituximab-abbs","rituximab-pvvr"],"DrugCentral":["4975"],"Wikipedia":["Rituximab"]},"count":127,"approvedIndications":["EFO_0000616","MONDO_0000873","EFO_0000685","EFO_0000220","EFO_0005297","EFO_0000095","MONDO_0000870","EFO_1000784","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0001423","EFO_0005952","MONDO_0018896","EFO_1000318","MONDO_0015760","Orphanet_1334","EFO_0000096","EFO_0002690","EFO_1000956","EFO_0000339","EFO_0003884","EFO_0004991","EFO_0004288","EFO_0000198","MONDO_0013730","MONDO_0019465","EFO_0001642","EFO_1001946","EFO_0008610","MONDO_0008315","EFO_0000384","MONDO_0019139","EFO_0007187","EFO_1001365","MONDO_0044889","EFO_0003032","EFO_0008520","EFO_0000574","EFO_0004256","EFO_0001378","EFO_1000550","MONDO_0015564","EFO_0003086","EFO_0007498","MONDO_0021117","EFO_0000255","MONDO_0004095","MONDO_0003541","EFO_1001486","EFO_0009606","EFO_0009562","EFO_0003100","EFO_0004289","EFO_1000630","MONDO_0004695","EFO_0007208","EFO_0004826","EFO_0000183","EFO_0005140","EFO_0000707","MONDO_0002083","Orphanet_797","EFO_0000616","EFO_0003897","EFO_0000765","EFO_0000772","EFO_1000868","EFO_1001779","MONDO_0019457","HP_0000093","EFO_0000403","EFO_0003898","EFO_0000222","EFO_0003929","MONDO_0000870","MONDO_0018170","EFO_0004599","EFO_0003885","EFO_0000304","EFO_0005297","Orphanet_238510","EFO_0007359","MONDO_0018906","EFO_0000557","MONDO_0024880","EFO_0004540","EFO_0000729","MONDO_0000873","EFO_0003869","EFO_0003780","EFO_1000131","EFO_0000540","EFO_0000565","EFO_0000309","EFO_0007160","EFO_0004251","Orphanet_365","EFO_0002612","HP_0001871","MONDO_0019088","EFO_0000389","EFO_0004255","EFO_0004244","EFO_0007332","Orphanet_98878","EFO_0000692","EFO_0008522","EFO_1000749","EFO_0004719","EFO_0009441","EFO_0002689","EFO_0005761","EFO_0004145","EFO_0000220","EFO_1001466","EFO_1000157","EFO_0004236","EFO_0004194","MONDO_0044881","EFO_1000784","EFO_1001050","EFO_0003840","MONDO_0001023","MONDO_0044917","EFO_0001359","EFO_1001051","EFO_0000699","MONDO_0009348","Orphanet_232","EFO_0000768","MONDO_0044887","EFO_0003778","EFO_1001469","EFO_0000209","MONDO_0002462","EFO_1001264","HP_0001915","EFO_1002048","HP_0000083","MONDO_0001718","EFO_1000783","EFO_0000474","EFO_0005531","EFO_0004254","EFO_0003860","EFO_0003144","Orphanet_309144","MONDO_0020743","EFO_0000717","MONDO_0001437","EFO_0010580","EFO_0002617","EFO_0000685","EFO_0000621","EFO_1001383","EFO_0000311","HP_0012664","MONDO_0001549","EFO_0000095","EFO_0000191"],"count":150},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 9 approved and 118 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201745","canonicalSmiles":"CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)[O-].C[N+](C)(C)CCO","inchiKey":"JWAZHODZSADEHB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLINE FENOFIBRATE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL981","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trilipix"],"synonyms":["ABT-335","Choline fenofibrate","Fenofibric acid choline salt"],"crossReferences":{"DailyMed":["choline%20fenofibrate"]},"count":4,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["HP_0003124","EFO_0001645","Orphanet_79211","EFO_0000319","EFO_0009321","Orphanet_309005"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for cardiovascular disease and has 3 investigational indications."}
{"id":"CHEMBL1201784","canonicalSmiles":"CCCCCCOC(=O)CCC(=O)CN","inchiKey":"RYQOILLJDKPETL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAMINOLEVULINATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hexaminolevulinate"],"crossReferences":{"drugbank":["DB06261"]},"childChemblIds":["CHEMBL1201785"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 3 investigational indications."}
{"id":"CHEMBL1234640","canonicalSmiles":"O=P(O)(O)O[P@](=O)(O)OC[C@H]1O[C@@H](n2cnc3c(NCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"MRHGMAGSDAQUFH-LSCFUAHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234640","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01893"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236602","canonicalSmiles":"O=C(O)/C=C/c1c[nH]cn1","inchiKey":"LOIYMIARKYCTBW-OWOJBTEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Imidazoleacrylic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Imidazoleacrylic Acid"],"crossReferences":{"PubChem":["111433","11532901","144210176","50107206","56422865","90341479"],"drugbank":["DB01971"],"chEBI":["30817"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256665","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC.Cl","inchiKey":"IWSWDOUXSCRCKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERAZOSIN HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL611","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204225","170465073","50107055","56422163","861987"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256722","canonicalSmiles":"C[C@H]1C=C(c2csc(SC3=C(C(=O)O)N4C(=O)[C@H]([C@@H](C)O)[C@H]4[C@H]3C)n2)CN1","inchiKey":"XFGOMLIRJYURLQ-GOKYHWASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAZUPENEM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PZ-601","Razupenem","SM-216601","SMP-601"],"crossReferences":{"drugbank":["DB12587"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1276342","canonicalSmiles":"CO[C@@]1(NC(=O)CSC[C@@H](N)C(=O)O)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21","inchiKey":"JSDXOWVAHXDYCU-VXSYNFHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFMINOX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefminox","Cefminox sodium"],"crossReferences":{"drugbank":["DB09062"]},"childChemblIds":["CHEMBL3184670"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1324","canonicalSmiles":"Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1","inchiKey":"MIQPIUSUKVNLNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOLCAPONE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," Canada"," Ireland"," Portugal"," Australia"],"classes":["Hepatotoxicity"],"year":1998},"tradeNames":["Tasmar","Tolcapone"],"synonyms":["RO 40-7592","RO-40-7592","RO-407592","Tolcapone"],"crossReferences":{"DailyMed":["tolcapone"],"PubChem":["144206516","144212731","170465081","50126317"],"Wikipedia":["Tolcapone"],"drugbank":["DB00323"],"chEBI":["63630"]},"count":11,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000093010"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","EFO_0003096","EFO_0002508","EFO_0003768","Orphanet_271861","EFO_0000621","EFO_0003829","EFO_0007046","MONDO_0002046","EFO_0003890","EFO_0004699","MONDO_0043510","EFO_0004242","EFO_0000692"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for parkinson's disease and has 10 investigational indications. It was withdrawn in European Union,  Canada,  Ireland,  Portugal and  Australia initially in 1998 due to Hepatotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1356238","canonicalSmiles":"[O-][n+]1ccccc1S","inchiKey":"FGVVTMRZYROCTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRITHIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["57260394"],"drugbank":["DB06815"],"chEBI":["36584"]},"childChemblIds":["CHEMBL1200471","CHEMBL2364542"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1410","canonicalSmiles":"CCCCCCCCCc1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1","inchiKey":"FBWNMEQMRUMQSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NONOXYNOL 9","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["C-film","Conceptrol","Delfen","Double check","Duragel","Emko","Gygel","Gynol 11","Gynol ii","Intercept","Ortho-creme","Ortho-forms","Prelude","Semicid","Today","Today sponge"],"synonyms":["Nonoxinol 9","Nonoxynol 9","Nonoxynol-9","Nonylphenoxypolyethoxyethanol"],"crossReferences":{"PubChem":["26749924"],"Wikipedia":["Nonoxynol-9"],"drugbank":["DB06804"],"chEBI":["53775"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1414320","canonicalSmiles":"CCCCC1(COC(=O)CCC(=O)O)C(=O)N(c2ccccc2)N(c2ccccc2)C1=O","inchiKey":"ONWXNHPOAGOMTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUXIBUZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Suxibuzone"],"crossReferences":{"PubChem":["11112710","124882557","144204166","144209550","144213095","170465972","56463081"],"Wikipedia":["Suxibuzone"],"drugbank":["DB13232"],"chEBI":["32173"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL141966","canonicalSmiles":"CCOCn1c(SC2CCCCC2)c(C(C)C)c(=O)[nH]c1=O","inchiKey":"JKXLRLDPSLZEDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TNK-6123","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TNK-6123"],"crossReferences":{"drugbank":["DB07184"],"chEBI":["62748"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1427664","canonicalSmiles":"CC(=O)OCC[N+](C)(C)C.[Br-]","inchiKey":"ZEHGKSPCAMLJDC-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1427664","maximumClinicalTrialPhase":0,"parentId":"CHEMBL667","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56422366","855511"],"chEBI":["55316"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1449676","canonicalSmiles":"Cc1ncc([N+](=O)[O-])n1CC(O)CCl","inchiKey":"IPWKIXLWTCNBKN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORNIDAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tiberal"],"synonyms":["NSC-95075","Ornidazole","RO 7-0207","RO-7-0207","RO-70207"],"crossReferences":{"PubChem":["144204133","170466243","855702"],"drugbank":["DB13026"],"chEBI":["75176"]},"count":3,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 2 investigational indications."}
{"id":"CHEMBL1451179","canonicalSmiles":"CCCC(O)C(CC)CO","inchiKey":"RWLALWYNXFYRGW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHOHEXADIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethohexadiol","Ethylhexanediol","Etohexadiol"],"crossReferences":{"PubChem":["144209201","144213570","170465521","17389337"],"Wikipedia":["Etohexadiol"],"drugbank":["DB13826"],"chEBI":["34273"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1533310","canonicalSmiles":"Cl.Cl.NCCc1c[nH]cn1","inchiKey":"PPZMYIBUHIPZOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HISTAMINE DIHYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL90","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceplene"],"synonyms":["Histamine dihydrochloride","Histamine dihydrocloride","Histamine hydrochloride","NSC-257873"],"crossReferences":{"PubChem":["50106398"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1551","canonicalSmiles":"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"RUDATBOHQWOJDD-UZVSRGJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URSODIOL","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actigall","Cholurso","Destolit","Urdox","Urso","Urso 250","Urso forte","Ursodiol","Ursofalk","Ursogal"],"synonyms":["NSC-683769","Ursodeoxycholic acid","Ursodesoxycholic acid","Ursodiol"],"crossReferences":{"DailyMed":["ursodiol"],"PubChem":["11532904"],"Wikipedia":["Ursodiol"],"drugbank":["DB01586"],"chEBI":["9907"]},"childChemblIds":["CHEMBL2028234"],"count":20,"linkedTargets":{"rows":["ENSG00000012504"],"count":1},"linkedDiseases":{"rows":["EFO_1000905","EFO_0003095","EFO_0000373","EFO_1001486","EFO_1001951","EFO_0002950","EFO_0005240","Orphanet_733","EFO_0003884","MONDO_0015183","HP_0002910","HP_0012378","HP_0001952","EFO_0004799","EFO_1000864","EFO_0001074","EFO_0004210","MONDO_0001751","MONDO_0019072","EFO_0002508","HP_0002014","EFO_0001073","EFO_0001422","MP_0001845","Orphanet_399","EFO_0004268","EFO_0004220","EFO_1001068","EFO_0001421","EFO_0001360"],"count":30},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 20 investigational indications."}
{"id":"CHEMBL1564","canonicalSmiles":"CN1CCC(OC(c2ccccc2)c2ccccc2)CC1.Cl","inchiKey":"LPRLDRXGWKXRMQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENYLPYRALINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1492","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hispril","Histryl","Histryl paed","Lergoban"],"synonyms":["Diphenylpyraline HCl","Diphenylpyraline hydrochloride","Diphenylpyraline teoclate"],"crossReferences":{"PubChem":["11532996","144203970","170464816","26748003","26748004"],"chEBI":["31508"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL158","canonicalSmiles":"C[C@H]1[C@H](NC(=O)/C(=N\\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O","inchiKey":"WZPBZJONDBGPKJ-VEHQQRBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZTREONAM","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azactam","Aztreonam","Cayston"],"synonyms":["Azactam","Aztreonam","NSC-646279","SO 26776","SQ 26776","SQ-26776"],"crossReferences":{"DailyMed":["aztreonam"],"Wikipedia":["Aztreonam"],"drugbank":["DB00355"],"chEBI":["161680"]},"childChemblIds":["CHEMBL3833340"],"count":11,"approvedIndications":["EFO_0003106","HP_0100806","EFO_0003103","EFO_0000771","EFO_0000544","EFO_1001141"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 6 approved and 5 investigational indications."}
{"id":"CHEMBL159","canonicalSmiles":"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1","inchiKey":"JXLYSJRDGCGARV-CFWMRBGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINBLASTINE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-47842","Velban","Vinblastine","[3H]-Vinblastine"],"crossReferences":{"DailyMed":["vinblastine%20sulfate"],"Wikipedia":["Vinblastine"],"drugbank":["DB00570"]},"childChemblIds":["CHEMBL378544"],"count":24,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["MONDO_0009348","EFO_0000292","EFO_0004708","EFO_0004281","MONDO_0003751","MONDO_0004192","EFO_0000756","EFO_0000681","EFO_0005952","MONDO_0020654","MONDO_0001187","EFO_0000565","EFO_1000318","EFO_0000588","MONDO_0002974","EFO_0000389","MONDO_0008903","EFO_0000326","EFO_0000183","MONDO_0003659","EFO_0002617","EFO_1000158","EFO_0000616","MONDO_0007608","EFO_0000220","MONDO_0008170","EFO_0000403","Orphanet_636","EFO_0003060","MONDO_0008315","EFO_0000211","EFO_0006818","MONDO_0018201","EFO_0000574","MONDO_0002367","EFO_0006544","EFO_0000691","MONDO_0021637"],"count":38},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and is indicated for neoplasm and has 23 investigational indications."}
{"id":"CHEMBL1615234","canonicalSmiles":"CO[C@@H]1/C=C/[C@H](C)[C@@H](O)C[C@@H](OC)/C=C/[C@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@@H](C)CCC(=O)[C@H](C)[C@@H](C/C=C/N(C)C=O)OC)OC(=O)/C=C/C=C(/C)C[C@@H](OC)CC2=CC(=O)O[C@H]([C@H]2O)[C@H](C)[C@@H](OC)C1","inchiKey":"MINVLQAHLUCDIO-GLLDUQGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPHINXOLIDE B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04783"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1615993","canonicalSmiles":"COc1ccc2[nH]c(-c3cccc(F)c3)cc(=O)c2c1OP(=O)(O)O","inchiKey":"ZDWFMAHQGDEALT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSLINANIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CVM-1118","CVM-1118 FREE ACID","Cvm-1118","Foslinanib","TRX-818","TRX-818 FREE ACID","Trx 818"],"childChemblIds":["CHEMBL1277519"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1651990","canonicalSmiles":"Clc1ccc(C(Cn2ccnc2)OCc2ccc(Sc3ccccc3)cc2)c(Cl)c1","inchiKey":"ZCJYUTQZBAIHBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENTICONAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fenticonazole"],"crossReferences":{"PubChem":["170466486"],"drugbank":["DB13434"],"chEBI":["83602"]},"childChemblIds":["CHEMBL2107703"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL168640","canonicalSmiles":"COC(=O)N[C@H](C(=O)NCCCC[C@@H](CO)N(CC(C)C)S(=O)(=O)c1ccc(N)cc1)C(c1ccccc1)c1ccccc1","inchiKey":"QAHLFXYLXBBCPS-IZEXYCQBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PPL-100","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-8122","MX-100","PL 100 (PHARMACEUTICAL)","PL-100","PPL 100","Ppl-100","TMB-607","Tmb-607"],"crossReferences":{"drugbank":["DB05961"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1729803","canonicalSmiles":"CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21","inchiKey":"MSPRUJDUTKRMLM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAROVERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Caroverine"],"crossReferences":{"PubChem":["144207061","174006990","90341829"],"drugbank":["DB13835"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743007","drugType":"Antibody","blackBoxWarning":false,"name":"DARATUMUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["3003-005","Daratumumab","HUMAX-CD 38","HuMax-CD38"],"crossReferences":{"DailyMed":["daratumumab"],"DrugCentral":["5063"]},"count":27,"approvedIndications":["EFO_0000616","EFO_0001378","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000004468"],"count":1},"linkedDiseases":{"rows":["EFO_0003073","EFO_0000249","EFO_1001469","EFO_0005952","Orphanet_85443","EFO_1001951","EFO_0000330","EFO_0000673","EFO_0000183","EFO_0000198","EFO_0009441","EFO_0000616","MONDO_0019465","EFO_0000220","EFO_0000349","EFO_0000403","EFO_1001875","EFO_0000222","EFO_0004599","MONDO_0008315","EFO_0003060","EFO_0006738","EFO_0000311","EFO_0000203","EFO_0000304","EFO_0000095","EFO_0006475","EFO_0000574","EFO_0006544","EFO_0001378","MONDO_0018906","EFO_1001051","EFO_1001115"],"count":33},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved and 24 investigational indications."}
{"id":"CHEMBL1790041","canonicalSmiles":"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1","inchiKey":"VMXUWOKSQNHOCA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RANITIDINE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ranitidine","Tritec","Zantac"],"crossReferences":{"DailyMed":["ranitidine%20hydrochloride"],"PubChem":["170465134"],"TG-GATEs":["86"],"Wikipedia":["Ranitidine"],"drugbank":["DB00863"]},"childChemblIds":["CHEMBL2110372","CHEMBL2111286"],"count":19,"approvedIndications":["HP_0004398","EFO_0003948"],"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["Orphanet_2314","HP_0012735","EFO_0005592","EFO_0000681","EFO_0005252","MONDO_0007254","MONDO_0043839","EFO_0009579","EFO_0000540","HP_0004398","EFO_0003948","MONDO_0015277","EFO_1000961","EFO_0000616","EFO_0000280","EFO_0001645","EFO_0009658","EFO_0003929","MONDO_0008315","EFO_1001355","EFO_0000311","EFO_0008533","EFO_0003885","EFO_0009454","MONDO_0044917","EFO_0000764","EFO_0001378","EFO_1001095"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for peptic ulcer and gastroesophageal reflux disease and has 17 investigational indications."}
{"id":"CHEMBL1885671","canonicalSmiles":"CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1.O=C(O)/C=C\\C(=O)O","inchiKey":"YNQQEYBLVYAWNX-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1885671","maximumClinicalTrialPhase":0,"parentId":"CHEMBL534","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["93576624"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1889091","canonicalSmiles":"CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1.Cl","inchiKey":"MSIJLVMSKDXAQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORCYCLIZINE HYDROCHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL22150","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Di-paralene"],"synonyms":["AH-289","Chlorcyclizine hydrochloride","NSC-169496"],"crossReferences":{"PubChem":["144204062","56463096"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1909282","canonicalSmiles":"O=C(O)Cc1csc(-c2ccc(Cl)cc2)n1","inchiKey":"APBSKHYXXKHJFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENCLOZIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"],"classes":["Hepatotoxicity"],"year":1970},"tradeNames":[],"synonyms":["Fenclozic acid","I.C.I. 54,450"],"crossReferences":{"PubChem":["144205372","170466565","29216130"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom and  United States initially in 1970 due to Hepatotoxicity."}
{"id":"CHEMBL1963683","canonicalSmiles":"CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/C(F)(F)COc1ccccc1","inchiKey":"WSNODXPBBALQOF-VEJSHDCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAFLUPROST","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Saflutan","Zioptan"],"synonyms":["AFP-168","MK-2452","Tafluprost"],"crossReferences":{"DailyMed":["tafluprost"],"Wikipedia":["Tafluprost"],"drugbank":["DB08819"],"chEBI":["66899"]},"count":3,"approvedIndications":["EFO_0004190","EFO_1001069","EFO_0000516"],"linkedTargets":{"rows":["ENSG00000122420"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","EFO_0000516"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 approved indications."}
{"id":"CHEMBL200255","canonicalSmiles":"NS(=O)(=O)c1ccc(CNC(=O)c2cn[nH]c2-c2cc(Cl)c(O)cc2O)cc1","inchiKey":"OOHYJGNSESWEFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200255","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04588"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2062266","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O=C(O)C(O)C(O)C(=O)O","inchiKey":"ZGSZBVAEVPSPFM-FFHNEAJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROCODEINE BITARTRATE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1595","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["DF 118","DF-118","Dihydrocodeine bitartrate","Dihydrocodeine bitartrate cii","Dihydrocodeine phosphate","Dihydrocodeine tartrate","Dihydroneopine","Drocode","NSC-117857"],"crossReferences":{"DailyMed":["dihydrocodeine%20bitartrate"]},"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983 and is indicated for pain."}
{"id":"CHEMBL206815","canonicalSmiles":"CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCO)cc2)[C@H]1C(=O)NO","inchiKey":"MAVDNGWEBZTACC-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APRATASTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apratastat","TMI-005","TMI-05"],"crossReferences":{"drugbank":["DB13020"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL207496","canonicalSmiles":"N[C@H](COc1cncc2nc(-c3ccncc3)ccc12)Cc1c[nH]c2ccccc12","inchiKey":"DQIXTEDFNFZMCM-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL207496","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07204"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2093999","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC(=O)[C@H]4CC(=NOCCN)CC[C@@]43C)[C@@H]1CCC2=O","inchiKey":"MPYLDWFDPHRTEG-IFVNMTGRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISTAROXIME","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(E,Z)-Istaroxime","Istaroxime","PST-2744"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2104391","canonicalSmiles":"CCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc3ccccc3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2)[C@@H](C)O)C(=O)O","inchiKey":"UGOZVNFCFYTPAZ-IOXYNQHNSA-N","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN DETEMIR","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ins levemir","Levemir","Levemir flexpen","Levemir flextouch","Levemir innolet","Levemir penfill"],"synonyms":["Insulin detemir","Insulin detemir recombinant","NN-304"],"crossReferences":{"DailyMed":["insulin%20detemir%20recombinant"],"DrugCentral":["4985"]},"count":7,"approvedIndications":["EFO_0001359","EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","HP_0003124","EFO_0001359","EFO_0001645","HP_0003074","Orphanet_586","EFO_0001360","EFO_0000400","EFO_0000537"],"count":9},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL2104805","canonicalSmiles":"CC1CN2CC(=O)Nc3ccc(Cl)cc3C2(c2ccccc2)O1","inchiKey":"VCCZBYPHZRWKFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXAZOLAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxazolam"],"crossReferences":{"drugbank":["DB15491"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105566","canonicalSmiles":"CC(Cc1ccccc1)NCCC#N","inchiKey":"IQUFSXIQAFPIMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENPROPOREX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenproporex"],"crossReferences":{"drugbank":["DB01550"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105832","canonicalSmiles":"CCCCCCCCN=c1ccn(CCCCCCCCCCn2ccc(=NCCCCCCCC)cc2)cc1.O=C1NS(=O)(=O)c2ccccc21.O=C1NS(=O)(=O)c2ccccc21","inchiKey":"OBHFLBIBWSFADO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTENIDINE SACCHARIN","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1199480","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octenidine saccharin","WIN 41,464-6"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105891","canonicalSmiles":"CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C.CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C.O=S(=O)(O)O","inchiKey":"YYBNDIVPHIWTPK-KYJQVDHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHYSOSTIGMINE SULFATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL94","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eserine sulfate"],"synonyms":["Physostigmine sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2105967","canonicalSmiles":"O=C(CCCCCCCC(=O)NCCO)NCCO","inchiKey":"PAHZPHDAJQIETD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADELMIDROL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adelmidrol"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105992","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[K+]","inchiKey":"DNAXYSPCMDEAQB-GJUCOGTPSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENICILLIN POTASSIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1214","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbenicillin potassium","GS-3159"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107966","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYGLYCONATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Maxon"],"synonyms":["MAS-1","Polyglyconate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108134","drugType":"Small molecule","blackBoxWarning":false,"name":"POLOXAMER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lutrol f","Pluracare","Pluronic"],"synonyms":["Poloxamer","Poloxamer-188"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108175","drugType":"Unknown","blackBoxWarning":false,"name":"ANTIHEMOPHILIC FACTOR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Alphanate","Bioclate","Haemate-p","Helixate","Hemofil m","Humafac","Humate-p","Koate-hp","Kogenate","Monoelate-p","Profilate heat-treated","Profilate hp","Profilate osd","Profilate sd"],"synonyms":["Antihemophilic factor","Antihemophilic factor, human"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108380","drugType":"Protein","blackBoxWarning":false,"name":"LIATERMIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gdnf liatermin","Liatermin"],"count":1,"linkedTargets":{"rows":["ENSG00000151892"],"count":1},"linkedDiseases":{"rows":["EFO_0002508"],"count":1},"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108459","drugType":"Antibody","blackBoxWarning":false,"name":"FONTOLIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fontolizumab","HUZAF"],"count":1,"linkedTargets":{"rows":["ENSG00000111537"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108574","drugType":"Unknown","blackBoxWarning":false,"name":"ANTITHROMBIN III HUMAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kybernin","Thrombate iii"],"synonyms":["Antithrombin iii","Antithrombin iii human","At iii","ORG 10849"],"count":3,"approvedIndications":["HP_0004419"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for recurrent thrombophlebitis and has 2 investigational indications."}
{"id":"CHEMBL2108703","drugType":"Enzyme","blackBoxWarning":false,"name":"LIPROTAMASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Theraclec","Trizytek"],"synonyms":["ALTU-135","Liprotamase"],"count":2,"description":"Enzyme drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108785","drugType":"Antibody","blackBoxWarning":false,"name":"ZOLIMOMAB ARITOX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Orthozyme cd5 plus"],"synonyms":["H65-RTA","ZX-CD5","Zolimomab aritox"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109191","drugType":"Antibody","blackBoxWarning":false,"name":"GALIXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Galiximab","IDEC-114"],"count":2,"linkedTargets":{"rows":["ENSG00000121594"],"count":1},"linkedDiseases":{"rows":["EFO_0000574","EFO_0005952"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109302","drugType":"Antibody","blackBoxWarning":false,"name":"MU-11-1F4 124I","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MU-11-1F4","Mu-11-1f4 124i"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109334","drugType":"Antibody","blackBoxWarning":false,"name":"INEBILIZUMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Uplizna"],"synonyms":["Inebilizumab","Inebilizumab-cdon","MEDI-551","MEDI551"],"crossReferences":{"DailyMed":["inebilizumab-cdon"]},"count":10,"approvedIndications":["EFO_0004256"],"linkedTargets":{"rows":["ENSG00000177455"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0000095","EFO_0001642","MONDO_0017287","EFO_0000403","EFO_0004256","EFO_1001993","EFO_0000574","EFO_0007332","EFO_0001378","EFO_0004991","EFO_0000311"],"count":12},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for neuromyelitis optica and has 9 investigational indications."}
{"id":"CHEMBL2109488","drugType":"Antibody","blackBoxWarning":false,"name":"INCLACUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Inclacumab","LC-1004-002","LC1004-002","RG1512","RO-4905417","RO4905417"],"count":3,"linkedTargets":{"rows":["ENSG00000174175"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0000612","EFO_0004265"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109512","drugType":"Antibody","blackBoxWarning":false,"name":"MCS-110","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MCS-110","Mcs-110"],"count":4,"linkedTargets":{"rows":["ENSG00000184371"],"count":1},"linkedDiseases":{"rows":["MONDO_0001056","EFO_0005922","EFO_0000756","MONDO_0007254"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109610","drugType":"Antibody","blackBoxWarning":false,"name":"HUMIK-BETA-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUMIK-BETA-1","Humik-beta-1"],"count":3,"linkedTargets":{"rows":["ENSG00000100385"],"count":1},"linkedDiseases":{"rows":["EFO_0001060","EFO_0007316","MONDO_0019469"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109619","drugType":"Antibody","blackBoxWarning":false,"name":"TCN-032","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TCN-032","Tcn-032"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110560","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTETATE CALCIUM TRISODIUM YB","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL1200698"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL2165620","canonicalSmiles":"O=C(O)c1ccc(NC(=O)[C@H](CC2CCCC2)n2cnc(C(F)(F)F)c2)nc1","inchiKey":"GKMLFBRLRVQVJO-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04991532","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-04991532"],"crossReferences":{"drugbank":["DB11765"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL223339","canonicalSmiles":"NC[C@H](c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1","inchiKey":"HWVGILTYGZFGLR-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL223339","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07858"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2272076","canonicalSmiles":"Cc1c(C(=O)c2cnn(C)c2O)ccc(S(C)(=O)=O)c1C1=NOCC1","inchiKey":"IYMLUHWAJFXAQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOPRAMEZONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAS-670H","Impact","Topramezone"],"crossReferences":{"PubChem":["144212758"],"drugbank":["DB14826"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL233406","canonicalSmiles":"O=S(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"PMZURENOXWZQFD-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM SULFATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glaubers Salt","Golytely"],"synonyms":["Anhydrous sodium sulfate","E-514(I)","E-514(II)","E514","INS NO.514(I)","INS NO.514(II)","INS-514(I)","INS-514(II)","Mirabilite","NSC-71192","Sodium bisulfate","Sodium sulfate","Sodium sulfate decahydrate"],"crossReferences":{"DailyMed":["sodium%20sulfate","sodium%20sulfate%20anhydrous"],"DrugCentral":["4212"],"PubChem":["144208243"],"Wikipedia":["Sodium_sulfate"],"drugbank":["DB09472"],"chEBI":["32149"]},"childChemblIds":["CHEMBL3989856"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984."}
{"id":"CHEMBL2364623","canonicalSmiles":"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CCN)OC[C@]1(C)O.O=S(=O)(O)O","inchiKey":"SFTBRKHJMASSAP-BGJNVEJLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PLAZOMICIN SULFATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1650559","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zemdri"],"synonyms":["ACHN-490","Plazomicin sulfate"],"count":2,"approvedIndications":["EFO_0003103","EFO_1001141"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for urinary tract infection and pyelonephritis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL237127","canonicalSmiles":"Cc1ccc(O)cc1Nc1ccnc2cc(-c3csc(C=O)n3)ccc12","inchiKey":"VKQPTVJDZIILPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL237127","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07832"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2431525","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O","inchiKey":"BQOIJSIMMIDHMO-FBPKJDBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2431525","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01485"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2435707","canonicalSmiles":"CCCCOc1c(OCCCC)c(=O)c1=O","inchiKey":"XBRWELTXMQSEIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SQUARIC ACID DIBUTYL ESTER","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-113489","Squaric acid dibutyl ester","Squaric acid dibutylester"],"crossReferences":{"drugbank":["DB12223"],"chEBI":["53612"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL24563","canonicalSmiles":"CCCCCCCCCO","inchiKey":"ZWRUINPWMLAQRD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NONANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Nonanol","Nonan-1-ol"],"crossReferences":{"PubChem":["144211186"],"Wikipedia":["1-Nonanol"],"drugbank":["DB03143"],"chEBI":["35986"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253582","canonicalSmiles":"OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"CZMRCDWAGMRECN-UGDNZRGBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUCROSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GNE-410","NSC-406942","S-67F","Sucrose"],"crossReferences":{"PubChem":["144205646","144208595","144210728","26757665"],"Wikipedia":["Sucrose"],"drugbank":["DB02772"],"chEBI":["17992"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL259084","canonicalSmiles":"O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1","inchiKey":"HHFBDROWDBDFBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MLN-8054","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MLN 8054","MLN-8054","Mln-8054"],"crossReferences":{"PubChem":["103904597","174006403","50100109"],"drugbank":["DB13061"]},"childChemblIds":["CHEMBL3586469"],"count":4,"linkedTargets":{"rows":["ENSG00000087586"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003860","EFO_0004288","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL261723","canonicalSmiles":"O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)CO)OCc1ccccc1","inchiKey":"OACUXIVGLLCILS-ZEQRLZLVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL261723","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01871"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267495","canonicalSmiles":"CN(C(=O)/C=C/c1ccoc1)[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5","inchiKey":"XGZZHZMWIXFATA-UEZBDDGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALFURAFINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MT-9938","Nalfurafine"],"crossReferences":{"drugbank":["DB13471"]},"childChemblIds":["CHEMBL490665"],"linkedTargets":{"rows":["ENSG00000082556"],"count":1},"linkedDiseases":{"rows":["EFO_0003884","EFO_0001421"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL277100","canonicalSmiles":"CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1","inchiKey":"QKDHBVNJCZBTMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMAFLOXACIN","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," Germany"],"classes":["Hematological toxicity"," Hepatotoxicity"," Immune system toxicity"," Nephrotoxicity"],"year":1992},"tradeNames":[],"synonyms":["Omniflox","Temafloxacin"],"crossReferences":{"PubChem":["144206857"],"Wikipedia":["Temafloxacin"],"drugbank":["DB01405"],"chEBI":["77796"]},"childChemblIds":["CHEMBL2107495"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and is indicated for bacterial disease. It was withdrawn in United States,  United Kingdom and  Germany initially in 1992 due to Hematological toxicity,  Hepatotoxicity,  Immune system toxicity and  Nephrotoxicity."}
{"id":"CHEMBL282052","canonicalSmiles":"Cc1ccccc1-n1c(C)nc2ccccc2c1=O","inchiKey":"JEYCTXHKTXCGPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHAQUALONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Misuse"],"year":1984},"tradeNames":[],"synonyms":["CI-705","CN 38703","Methaqualone","QZ-2","R-148","TR-495"],"crossReferences":{"PubChem":["144206055","144206422","24804237"],"Wikipedia":["Methaqualone"],"drugbank":["DB04833"],"chEBI":["6821"]},"childChemblIds":["CHEMBL2106829"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1984 due to Misuse."}
{"id":"CHEMBL291657","canonicalSmiles":"C#CCN(c1nc(-c2cc(C)c(OC)cc2Cl)c(C)s1)[C@@H](CC1CC1)c1ccc(C)c(F)c1","inchiKey":"IEAKXXNRGSLYTQ-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SSR125543","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nbi-74788","Ssr125543"],"crossReferences":{"chEBI":["34969"]},"childChemblIds":["CHEMBL1628268"],"count":2,"linkedTargets":{"rows":["ENSG00000120088"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","Orphanet_418"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL296522","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)NC1CCN2CCCC1C2","inchiKey":"GZSKEXSLDPEFPT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RENZAPRIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATL-1251","Renzapride"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3039514","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc3c(c2)O[C@@H](c2ccccc2)n2c-3cc3cc(-c4c[nH]c([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)n4)ccc32)c[nH]1)C(C)C","inchiKey":"BVAZQCUMNICBAQ-PZHYSIFUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELBASVIR","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Elbasvir","MK-8742"],"crossReferences":{"DailyMed":["elbasvir"],"drugbank":["DB11574"]},"count":5,"approvedIndications":["EFO_0004220","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for viral disease and chronic hepatitis c virus infection and has 3 investigational indications."}
{"id":"CHEMBL3039523","canonicalSmiles":"CCC[C@@H](N(NC(=O)c1cccc(OC)c1CC)C(=O)c1cc(C)cc(C)c1)C(C)(C)C","inchiKey":"LZWZPGLVHLSWQX-XMMPIXPASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VELEDIMEX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INXN-1001","RG-115932","Veledimex"],"crossReferences":{"drugbank":["DB12170"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3039540","drugType":"Antibody","blackBoxWarning":false,"name":"ADUCANUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aducanumab","BIIB-037","BIIB037"],"count":1,"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3039547","drugType":"Gene","blackBoxWarning":false,"name":"PEXASTIMOGENE DEVACIREPVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JX-594","Pexastimogene devacirepvec"],"count":7,"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3140361","canonicalSmiles":"CC[C@@H](CO)NCCN[C@@H](CC)CO.Cl.Cl","inchiKey":"AUAHHJJRFHRVPV-BZDVOYDHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHAMBUTOL HYDROCHLORIDE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL44884","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ethambutol hydrochloride","Myambutol","Mynah 200","Mynah 250","Mynah 300","Mynah 365"],"synonyms":["CL 40881","CL-40881","Ethambutol dihydrochloride","Ethambutol hydrochloride"],"crossReferences":{"DailyMed":["ethambutol%20hydrochloride"],"PubChem":["144204045","170465115"],"chEBI":["4878"]},"count":4,"approvedIndications":["EFO_1000049"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for pulmonary tuberculosis and has 3 investigational indications."}
{"id":"CHEMBL3185390","canonicalSmiles":"CC(=O)Nc1ccc(S(=O)(=O)Cl)cc1","inchiKey":"GRDXCFKBQWDAJH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3185390","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209754"],"drugbank":["DB12337"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL31871","canonicalSmiles":"Cc1c(Sc2ccccc2)n(COCCO)c(=O)[nH]c1=O","inchiKey":"HDMHBHNRWDNNCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEPT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07892"],"chEBI":["43060"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL320358","canonicalSmiles":"CCCCCCC(=O)O","inchiKey":"MNWFXJYAOYHMED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEPTANOATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Heptanoate","Heptanoic Acid","Heptanoic Acid Anion"],"crossReferences":{"PubChem":["144209028","144210660","17389663"],"Wikipedia":["Heptanoic_acid"],"drugbank":["DB02938"],"chEBI":["45571"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3216010","canonicalSmiles":"CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl.Cl.Cl","inchiKey":"XASZDHUZFUQQKH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3216010","maximumClinicalTrialPhase":0,"parentId":"CHEMBL682","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL328827","canonicalSmiles":"Nc1nc(N)c2c(Sc3ccc(N4CCOCC4)cc3)cccc2n1","inchiKey":"CZLWCJRHDBTCGQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL328827","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL329203","canonicalSmiles":"CNC(C)CC1CCCC1","inchiKey":"HFXKQSZZZPGLKQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOPENTAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclopentamine"],"crossReferences":{"Wikipedia":["Cyclopentamine"],"drugbank":["DB08999"]},"childChemblIds":["CHEMBL2107277"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3301606","canonicalSmiles":"CC1(C)CN(C(=O)c2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)C1","inchiKey":"MPYACSQFXVMWNO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOLCITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G-154578","G154578","GLPG-0778","GLPG-0788","GLPG0778","GSK-2586184","GSK-2586184A","GSK2586184A","Glpg-0778","Gsk-2586184","Solcitinib"],"count":3,"linkedTargets":{"rows":["ENSG00000162434"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0002690","EFO_0000676"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3544933","drugType":"Small molecule","blackBoxWarning":false,"name":"VS-4718","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PND-1186","SR-2516","VS-4718","Vs-4718"],"count":3,"linkedTargets":{"rows":["ENSG00000169398"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000222","EFO_0000094","MONDO_0024880"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545011","canonicalSmiles":"O[C@@H]1[C@@H](CSc2ccccc2F)O[C@@H](n2cnc3c(N[C@@H]4CCC[C@H]4O)ncnc32)[C@@H]1O","inchiKey":"IZRXENCTXNMAMI-DIJFLQFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GS-9667","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CVT-3619","Gs-9667"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545059","canonicalSmiles":"COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC.COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC.O=C(O)/C=C/C(=O)O","inchiKey":"KLRSDBSKUSSCGU-KRQUFFFQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALISKIREN FUMARATE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1639","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tekturna"],"synonyms":["Aliskiren fumarate","Aliskiren hemifumarate","SPP-100B","SPP100"],"crossReferences":{"DailyMed":["aliskiren%20hemifumarate"],"chEBI":["53777"]},"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000143839"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2007 and is indicated for hypertension. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3545082","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7376","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PLX-5568","Rg-7376"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545371","drugType":"Antibody","blackBoxWarning":false,"name":"DENINTUZUMAB MAFODOTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Denintuzumab mafodotin","SGN-19A","SGN-CD19A"],"count":5,"linkedTargets":{"rows":["ENSG00000177455"],"count":1},"linkedDiseases":{"rows":["EFO_0000309","EFO_0000220","EFO_0000403","MONDO_0018906","EFO_1001469"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL358860","canonicalSmiles":"O=P(O)(O)Oc1cccc2c1NCCC2","inchiKey":"NSJSAHCLJYVEDM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL358860","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03525"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL359744","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl","inchiKey":"MWWSFMDVAYGXBV-RUELKSSGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DOXORUBICIN HYDROCHLORIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL53463","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adriamycin","Adriamycin Rdf","Adriamycin pfs","Caelyx","Doxil","Doxil (liposomal)","Doxorubicin hydrochloride","Doxorubicin hydrochloride (liposomal)","Myocet","Rubex"],"synonyms":["Doxorubicin HCl","Doxorubicin hydrochloride","Doxorubicin liposomal complex of the hydrochloride","Liposomal doxorubicin hydrochloride"],"crossReferences":{"DailyMed":["doxorubicin%20hydrochloride"],"PubChem":["144203601","144205614","144209681","170465451","17389199","49681823","49718188","50126368","855944"]},"count":84,"approvedIndications":["EFO_0001378"],"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["EFO_0004708","EFO_0000637","EFO_0003859","EFO_0000558","EFO_0000681","EFO_1000231","EFO_0005952","EFO_1000984","EFO_1001951","EFO_1001952","EFO_0000588","EFO_0000096","EFO_0000564","MONDO_0002974","MONDO_0008903","EFO_1000251","EFO_0002918","EFO_0000760","EFO_0000198","EFO_1001946","EFO_1001968","MONDO_0008315","MONDO_0002691","Orphanet_398934","EFO_1001365","EFO_0003032","MONDO_0044889","EFO_0000574","EFO_0001378","EFO_1000796","EFO_0001376","EFO_0000292","MONDO_0003175","MONDO_0007254","Orphanet_790","MONDO_0003541","MONDO_0020654","MONDO_0001056","MONDO_0002158","EFO_0003968","EFO_1001974","MONDO_0017387","MONDO_0012825","EFO_0000183","MONDO_0002083","MONDO_0002618","EFO_0000616","EFO_0006859","EFO_0000765","EFO_1000314","EFO_0000403","EFO_1001042","MONDO_0000870","EFO_0000222","MONDO_0007576","EFO_1001953","EFO_0000304","MONDO_0011962","EFO_0000702","EFO_1001947","MONDO_0002367","MONDO_0018906","MONDO_0024880","MONDO_0000873","EFO_0003869","EFO_0001075","EFO_1000131","EFO_0005561","EFO_0000565","EFO_0000309","EFO_0007160","EFO_0000182","MONDO_0015540","EFO_0000094","Orphanet_654","EFO_1000595","EFO_0003893","MONDO_0004658","EFO_1000292","EFO_0000220","EFO_0000248","MONDO_0008170","MONDO_0005094","EFO_0000502","EFO_0009708","EFO_0007143","EFO_1001100","EFO_1000238","EFO_0005537","MONDO_0044917","EFO_0006544","EFO_0000569","MONDO_0009348","MONDO_0004192","MONDO_0015686","EFO_1001469","EFO_0000209","MONDO_0002087","EFO_0000305","MONDO_0001187","Orphanet_31112","EFO_0000239","EFO_1000158","EFO_0000437","MONDO_0002678","EFO_0000313","EFO_0000621","EFO_0003060","EFO_0000311","EFO_0000211","EFO_0006861","EFO_0000095","EFO_0000174","EFO_0006475","MONDO_0002621","EFO_1001936","MONDO_0020077","EFO_0000691"],"count":118},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for multiple myeloma and has 83 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL360055","canonicalSmiles":"CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC","inchiKey":"OZLPUNFFCJDMJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GALLAMINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Gallamine"],"crossReferences":{"PubChem":["11111237","11111238","124880248","26756602","90341095"]},"childChemblIds":["CHEMBL1200993"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL367746","canonicalSmiles":"Nc1nc2cc[nH]c2c(=O)[nH]1","inchiKey":"FFYPRJYSJODFFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"9-Deazaguanine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-Deazaguanine"],"crossReferences":{"drugbank":["DB04356"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707281","canonicalSmiles":"CC(O)C(=O)[O-].CC(O)C(=O)[O-].[Mg+2]","inchiKey":"OVGXLJDWSLQDRT-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM LACTATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mag-tab sr"],"synonyms":["Magnesium lactate"],"crossReferences":{"DrugCentral":["4592"],"drugbank":["DB14515"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL371948","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@H](CCCCCCCCC(=O)OC[C@H]1O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]1O)[C@@H]2O","inchiKey":"CKSDYJASHNGOOS-KTXOUVACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL371948","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02323"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3794255","canonicalSmiles":"NCCO.O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O","inchiKey":"XYCDHXSQODHSLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3794255","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1448","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833319","canonicalSmiles":"CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1","inchiKey":"FYDWDCIFZSGNBU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REVEFENACIN","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Yupelri"],"synonyms":["GSK-1160724","GSK1160724","Revefenacin","TD-4208"],"crossReferences":{"DailyMed":["revefenacin"],"drugbank":["DB11855"]},"count":4,"approvedIndications":["HP_0006536","EFO_0000341"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0006536","EFO_0001421","EFO_0000341"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for chronic obstructive pulmonary disease and airway obstruction and has 2 investigational indications."}
{"id":"CHEMBL3833331","drugType":"Small molecule","blackBoxWarning":false,"name":"BIIB061","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB061","Biib061"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3924151","canonicalSmiles":"CNC(=N)NCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)NNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O","inchiKey":"MWXWMWSUUYXMRA-GRKBUMBKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-448","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tak-448"],"crossReferences":{"drugbank":["DB11975"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL396778","canonicalSmiles":"C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O","inchiKey":"NEMGRZFTLSKBAP-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAFINAMIDE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xadago"],"synonyms":["EMD 1195686","EMD-1195686","Safinamide"],"crossReferences":{"DailyMed":["safinamide%20mesylate"],"Wikipedia":["Safinamide"],"drugbank":["DB06654"]},"childChemblIds":["CHEMBL48582"],"count":4,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000069535"],"count":1},"linkedDiseases":{"rows":["EFO_1001050","EFO_0003086","EFO_0002508","EFO_0001421"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for parkinson's disease and has 3 investigational indications."}
{"id":"CHEMBL3989401","canonicalSmiles":"NCCC(O)(P(=O)([O-])O)P(=O)([O-])O.O.O.O.O.O.[Na+].[Na+]","inchiKey":"CZYWHNTUXNGDGR-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PAMIDRONATE DISODIUM","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL834","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aredia","Pamidronate disodium"],"synonyms":["CGP 23339AE","CGP-23339AE","Pamidronate disodium","Pamidronate disodium hydrate"],"crossReferences":{"DailyMed":["pamidronate%20disodium"]},"count":4,"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254","EFO_0001378","Orphanet_666","EFO_1001164"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 4 investigational indications."}
{"id":"CHEMBL3989834","canonicalSmiles":"COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccncc2)nc1OC","inchiKey":"YBWLTKFZAOSWSM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVOSENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avosentan","RO 67-0565","RO-67-0565","Ro670565","SPP-301","SPP301"],"count":1,"linkedTargets":{"rows":["ENSG00000151617"],"count":1},"linkedDiseases":{"rows":["EFO_0000401"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3989999","drugType":"Antibody","blackBoxWarning":false,"name":"LETOLIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986004","Letolizumab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL399121","canonicalSmiles":"COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O","inchiKey":"AIONOLUJZLIMTK-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HESPERETIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-57654"],"crossReferences":{"PubChem":["11112384","11112385","124882313","26754195","56463566"],"Wikipedia":["Hesperetin"],"drugbank":["DB01094"],"chEBI":["28230"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL401842","canonicalSmiles":"N=C(N)NOCCNC(=O)Cc1c(Cl)ccc(NCC(F)(F)c2ccccc2)c1F","inchiKey":"DZEJHPMTDNDECN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL401842","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07946"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4076124","canonicalSmiles":"CC(F)(F)c1cc(F)ccc1-c1sc2cc(O)ccc2c1Oc1ccc(/C=C/C(=O)O)cc1","inchiKey":"SJXNPGGVGZXKKI-NYYWCZLTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4076124","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15362"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL41632","canonicalSmiles":"O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1","inchiKey":"UOWZUVNAGUAEQC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIRATRICOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Levothyroxine sodium impurity, triiodothyroacetic acid, or t3-acetic acid-","T3-acetic acid","TRIAC","Tiratricol","Triiodothyroacetic acid"],"crossReferences":{"PubChem":["11112109","144203868","144213850","50100372","855525"],"Wikipedia":["Tiratricol"],"drugbank":["DB03604"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4170268","canonicalSmiles":"CCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2","inchiKey":"SVTKBAIRFMXQQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4170268","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14736"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL425616","canonicalSmiles":"CCn1c(Nc2ccccc2Cl)nc2cnc(Nc3c(F)cccc3F)nc21","inchiKey":"ZWKOUFZHPNIQSH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL425616","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08096"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL426815","canonicalSmiles":"NCc1ccc(NC(=O)C(=O)O)cc1","inchiKey":"RKILOCCSAVHHJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL426815","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02420"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL428880","canonicalSmiles":"O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1","inchiKey":"IMZMKUWMOSJXDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CROMOLYN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cromoglicic acid","Cromolyn","R03BC01"],"crossReferences":{"DailyMed":["cromolyn%20sodium"],"PubChem":["104171394","26751521","29215502","50103871","50123505"],"drugbank":["DB01003"],"chEBI":["59773"]},"childChemblIds":["CHEMBL74","CHEMBL351631"],"count":8,"approvedIndications":["HP_0006536","HP_0000964","EFO_0005751","HP_0001742"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 4 approved and 4 investigational indications."}
{"id":"CHEMBL4297064","canonicalSmiles":"CCN(CC)C(=O)C1(c2ccccc2)CC1CN.Cl","inchiKey":"XNCDYJFPRPDERF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MILNACIPRAN HYDROCHLORIDE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL259209","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dalcipran","Ixel","Milnacipran hydrochloride","Savella","Toledomin"],"synonyms":["Milnacipran hydrochloride"],"crossReferences":{"DailyMed":["milnacipran%20hydrochloride"]},"count":2,"approvedIndications":["EFO_0005687"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0005687","HP_0003418"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for fibromyalgia and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297212","canonicalSmiles":"Cl.NC(=O)OC[C@H](N)Cc1ccccc1","inchiKey":"KAOVAAHCFNYXNJ-SBSPUUFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOLRIAMFETOL HYDROCHLORIDE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL4297620","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sunosi"],"synonyms":["JZP-110 hydrochloride","Solriamfetol","Solriamfetol hydrochloride"],"crossReferences":{"DailyMed":["solriamfetol%20hydrochloride"]},"count":3,"approvedIndications":["EFO_0005246","EFO_0003877","EFO_0000614"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved indications."}
{"id":"CHEMBL4297384","canonicalSmiles":"CCn1ncc2c(NC3CCOCC3)c(-c3nnc(Cc4sc(C)nc4C)o3)cnc21","inchiKey":"AWDJJMXJUOHGLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-356278","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK356278","Gsk-356278","Gsk356278"],"crossReferences":{"drugbank":["DB12542"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297453","canonicalSmiles":"COc1c(C)cc2c(c1O)[C@@H]1[C@@H]3Cc4c(OC(C)=O)c(C)c5c(c4[C@H](CNC(=O)/C=C/c4cccc(C(F)(F)F)c4)N3[C@@H](O)[C@H](C2)N1C)OCO5","inchiKey":"VPAHZSUNBOYNQY-DLVGLDQCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PM-00104","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PM00104","Pm-00104","Zalypsis"],"crossReferences":{"drugbank":["DB12454"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297515","canonicalSmiles":"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(CCOC(=O)OCCN5CCN(S(=O)(=O)c6ccc(OCC)c(-c7nc8c(CCC)nn(C)c8c(=O)[nH]7)c6)CC5)CC4)ccc3OCC)nc12","inchiKey":"MVYUCRDXZXLFSB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LODENAFIL CARBONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lodenafil carbonate"],"crossReferences":{"drugbank":["DB11927"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297914","drugType":"Protein","blackBoxWarning":false,"name":"TALDEFGROBEP ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986089","Bms-986089","RO-7239361","RO7239361","Ro7239361","Taldefgrobep alfa","Talditercept alfa"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297946","drugType":"Unknown","blackBoxWarning":false,"name":"ENDOSTATIN, N-TERMINAL-MGGSHHHHH","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Endostar","Endostatin, n-terminal-mggshhhhh"],"count":20,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 20 investigational indications."}
{"id":"CHEMBL4298107","drugType":"Unknown","blackBoxWarning":false,"name":"SOBI-003","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SOBI-003","SOBI003","Sobi-003","Sobi003"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL430893","canonicalSmiles":"COc1ccc([C@@H]2CNC(=O)C2)cc1OC1CCCC1","inchiKey":"HJORMJIFDVBMOB-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(-)-ROLIPRAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-Rolipram","R-Rolipram"],"crossReferences":{"PubChem":["11112814","11113776","11113777","11113778","124882650","124882651"],"drugbank":["DB04149"],"chEBI":["40133"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL435982","canonicalSmiles":"N[C@H](C[C@H](Cc1ccc2ccccc2c1)C(=O)O)C(=O)O","inchiKey":"YDWIUFASTTZKNI-UONOGXRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL435982","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08272"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL446435","canonicalSmiles":"CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N(Cc2cnc3ccccc3c2)[C@@H](CC(C)C)C1=O","inchiKey":"COVPLULNDBDXTN-KYJUHHDHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL446435","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04724"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL453514","canonicalSmiles":"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O","inchiKey":"ACTOXUHEUCPTEW-CEUOBAOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPIRAMYCIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rovamycin","Rovamycine 250"],"synonyms":["Acetylspiramycin","IL 5902","IL-5902","NSC-55926","NSC-64393","RP 5337","RP-5337","Spiramycin","Spiramycin I"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL454138","canonicalSmiles":"CC(C)OC(=O)C1=CN(C(=O)c2ccc(F)c(F)c2)CC(C)(C)c2c1[nH]c1ccccc21","inchiKey":"INASOKQDNHHMRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TUROFEXORATE ISOPROPYL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FXR-450","Turofexorate isopropyl","WAY-362450","XL-335","XL335"],"crossReferences":{"PubChem":["137275949"],"drugbank":["DB12719"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594312","drugType":"Gene","blackBoxWarning":false,"name":"PRADEMAGENE ZAMIKERACEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EB-101","Eb-101","Prademagene zamikeracel"],"count":1,"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594314","drugType":"Protein","blackBoxWarning":false,"name":"TIMBETASIN ACETATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GBT-201","RGN-137","RGN-259","Rgn-137","Timbetasin acetate"],"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594377","canonicalSmiles":"C(=C/[C@H]1CCNC1)\\c1cncnc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"HVGZXVVUVQKTSC-OUCPDFHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMPINICLINE CITRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL4594254","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OC-02-cit","Simpinicline citrate","TC-6499-221"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594540","drugType":"Unknown","blackBoxWarning":false,"name":"APVO-414","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APVO-414","APVO414","Apvo-414","ES-414","ES414","Es414","MOR-209","MOR209"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594548","drugType":"Antibody","blackBoxWarning":false,"name":"VULINACIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HLX-06","HLX06","Hlx06","Vulinacimab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594587","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"ELUFORSEN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eluforsen","QR-010","Qr-010"],"count":1,"description":"Oligonucleotide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL46439","canonicalSmiles":"N[C@H]1CCc2ccccc2[C@@H]1O","inchiKey":"IIMSEFZOOYSTDO-UWVGGRQHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL46439","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08654"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL47","canonicalSmiles":"Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2","inchiKey":"GVJHHUAWPYXKBD-IEOSBIPESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VITAMIN E","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Alpha Tocopherol","Aquasol E","Tocopherol"],"synonyms":["E307","Tocopherol","Vitamin E"],"crossReferences":{"DrugCentral":["3613"],"PubChem":["144204114","144206759","144209279","26754431","29215204","47193687"],"Wikipedia":["Alpha-Tocopherol"],"drugbank":["DB00163"],"chEBI":["18145"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL473489","canonicalSmiles":"O=C(/C=C(\\O)c1nnn[nH]1)c1c[nH]c2ccc(Cl)cc12","inchiKey":"LKVXXMOMTRBUQI-WCIBSUBMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL473489","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03118"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL479843","canonicalSmiles":"CC(O)C[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"KOGFZZYPPGQZFZ-QVAPDBTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL479843","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13121"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL479960","canonicalSmiles":"NCC(=O)Nc1ccc(OCc2ccccc2)cc1","inchiKey":"YJPUATSIKWOSST-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL479960","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07099"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL492399","canonicalSmiles":"COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1","inchiKey":"SNHCRNMVYDHVDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERUBULIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Azixa"],"synonyms":["MPC-6827","MX-128495","Verubulin"],"crossReferences":{"drugbank":["DB05585"]},"childChemblIds":["CHEMBL3910844","CHEMBL2105697"],"count":3,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000137285","ENSG00000123416","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003833","EFO_0000519"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL493986","canonicalSmiles":"Cc1ccn(-c2ccc3c(c2)NCC3(C)C)c(=O)c1-c1ccc2nc(N)ncc2c1","inchiKey":"LHLGUOHREUTYTO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL493986","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07514"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL507419","canonicalSmiles":"Cc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1N","inchiKey":"XXYTXQGCRQLRHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METAHEXAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glyhexylamide","Metahexamide","Metahexanamide"],"crossReferences":{"Wikipedia":["Metahexamide"],"drugbank":["DB13675"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL513301","canonicalSmiles":"COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC","inchiKey":"YNZXWQJZEDLQEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMAZOSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trimazosin"],"crossReferences":{"Wikipedia":["Trimazosin"],"drugbank":["DB09206"]},"childChemblIds":["CHEMBL3989848"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL522","canonicalSmiles":"NCc1ccccc1","inchiKey":"WGQKYBSKWIADBV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminotoluene","Benzylamine"],"crossReferences":{"PubChem":["144211250","29217787"],"Wikipedia":["Benzylamine"],"drugbank":["DB02464"],"chEBI":["40538"]},"childChemblIds":["CHEMBL14186"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL553204","canonicalSmiles":"COc1ccc(-c2oc3c(CC=C(C)C)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c(=O)c2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)cc1","inchiKey":"TZJALUIVHRYQQB-XLRXWWTNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICARIIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epimedii herba icariin","Icariin"],"crossReferences":{"PubChem":["26719816"],"Wikipedia":["Icariin"],"drugbank":["DB12052"],"chEBI":["78420"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL558752","canonicalSmiles":"Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21","inchiKey":"YABJJWZLRMPFSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAF-265","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHIR-265","NVP-RAF265","RAF265","Raf 265","Raf-265"],"crossReferences":{"PubChem":["137275908","50100093"],"drugbank":["DB05984"]},"count":2,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000157764"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002617"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL562743","canonicalSmiles":"CC(=O)Nc1nc2c(s1)C(=O)NCCC2","inchiKey":"OYHOEDBNAJPFKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL562743","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24807477"],"drugbank":["DB08776"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL572546","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OS(=O)(=O)O)[C@@H](O)[C@H]1O","inchiKey":"IRLPACMLTUPBCL-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Adenosine-5'-Phosphosulfate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adenosine-5'-Phosphosulfate"],"crossReferences":{"drugbank":["DB03708"],"chEBI":["17709"]},"childChemblIds":["CHEMBL578658"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL572881","canonicalSmiles":"CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21","inchiKey":"RAHBGWKEPAQNFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOTESANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 706","AMG-706","Motesanib"],"crossReferences":{"PubChem":["137276049","50100087"],"drugbank":["DB05575"],"chEBI":["51098"]},"childChemblIds":["CHEMBL2107357"],"count":2,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000165731","ENSG00000102755","ENSG00000037280","ENSG00000157404","ENSG00000113721"],"count":7},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","MONDO_0021058","EFO_0007331","MONDO_0002108","MONDO_0008170","Orphanet_44890","EFO_1000657","MONDO_0007254","MONDO_0007576","MONDO_0021063","MONDO_0002087","EFO_0004243","EFO_0003060","MONDO_0002158","EFO_1000218","Orphanet_238510","MONDO_0008903","EFO_0000574"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL585","canonicalSmiles":"Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1","inchiKey":"FNYLWPVRPXGIIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRIAMTERENE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dyrenium","Dytac"],"synonyms":["NSC-639359","NSC-77625","SK&F 8542","SK&F-8542","SK-8542","Triamterene"],"crossReferences":{"DailyMed":["triamterene"],"PubChem":["104171252","11111878","11111879","124881638","124881640","144203834","144209219","144213150","170464706","17389703","26747035","26751552","50100356","50104154","50104155","85231255","855896","90341047"],"TG-GATEs":["101"],"Wikipedia":["Triamterene"],"drugbank":["DB00384"]},"count":10,"approvedIndications":["EFO_0001422","EFO_0004255","EFO_0000373","EFO_0000319","EFO_0000537","EFO_0009452"],"linkedTargets":{"rows":["ENSG00000111319"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","EFO_0001422","HP_0003124","HP_0000093","EFO_0001645","EFO_0004278","EFO_0004255","EFO_0000373","EFO_0000319","EFO_0001360","EFO_0000537","EFO_0009452"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 6 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL660","canonicalSmiles":"NC12CC3CC(CC(C3)C1)C2","inchiKey":"DKNWSYNQZKUICI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMANTADINE","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amantadine","NSC-341865","Symadine","Symmetrel","TCMDC-125869"],"crossReferences":{"DailyMed":["amantadine%20hydrochloride"],"PubChem":["104171100","11110715","124879107","144203619","170464860","26755640","26755641","50110918","50110919","90340894"],"Wikipedia":["Amantadine"],"drugbank":["DB00915"],"chEBI":["2618"]},"childChemblIds":["CHEMBL465617","CHEMBL1569","CHEMBL1445834"],"count":15,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000161509","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0003888","EFO_0002610","EFO_0002508","EFO_0005323","HP_0000726","MONDO_0002679","EFO_0003843","EFO_0000546","EFO_0003885","EFO_0004220","EFO_1001175","EFO_0004247","EFO_0000544","EFO_1001402","EFO_1000632","EFO_0007328","EFO_0003047","MONDO_0043510","EFO_0001360","EFO_0000692","EFO_1000860","EFO_0005411"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and is indicated for parkinson's disease and has 14 investigational indications."}
{"id":"CHEMBL6885","canonicalSmiles":"Nc1ccc2nc(N)nc(N)c2c1","inchiKey":"LJBWEZVYRBKOCI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINAZOLINE-2,4,6-TRIAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinazoline-2,4,6-Triamine"],"crossReferences":{"drugbank":["DB02532"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL76370","canonicalSmiles":"CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12","inchiKey":"IKBKZGMPCYNSLU-RGVLZGJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGASEROD","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"," Neurotoxicity"],"year":2007},"tradeNames":["Zelmac"],"synonyms":["HTF 919","SDZ-HTF-919","Tegaserod"],"crossReferences":{"DailyMed":["tegaserod%20maleate"],"PubChem":["144205034","170466887","26749090"],"Wikipedia":["Tegaserod"],"drugbank":["DB01079"],"chEBI":["51043"]},"childChemblIds":["CHEMBL533819","CHEMBL1516474","CHEMBL4303321"],"count":3,"approvedIndications":["HP_0002019"],"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_0000555","HP_0012450","HP_0002019","EFO_0008533"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for constipation and has 2 investigational indications. It was withdrawn in United States  in 2007 due to Cardiotoxicity and  Neurotoxicity."}
{"id":"CHEMBL846","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O","inchiKey":"GMRQFYUYWCNGIN-NKMMMXOESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCITRIOL","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcijex","Calcitriol","Dihydroxycholecalciferol","Dihydroxyvitamin D 3","Rocaltrol","Silkis","Topitriol","Vectical"],"synonyms":["1alpha,25-dihydroxycholecalciferol","1alpha,25-dihydroxyvitamin d3","Calcitriol","RO 21-5535","RO-21-5535","RO-215535"],"crossReferences":{"DailyMed":["calcitriol"],"PubChem":["144205541","26719902","50110818"],"Wikipedia":["Calcitriol"],"drugbank":["DB00136"],"chEBI":["17823"]},"childChemblIds":["CHEMBL578780"],"count":34,"approvedIndications":["HP_0002901","EFO_0003884","EFO_0000676","EFO_0009451"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["HP_0002901","EFO_0003869","EFO_1001173","EFO_1001494","EFO_0000401","MONDO_0007254","EFO_0009451","MONDO_0002462","EFO_0000274","EFO_0003882","EFO_1001152","EFO_0007160","EFO_0002690","Orphanet_733","Orphanet_89936","EFO_0003884","EFO_0000673","EFO_0000676","EFO_0004193","EFO_0002617","EFO_1000158","EFO_0000198","EFO_0003888","EFO_0000616","EFO_0002618","HP_0001919","HP_0000093","EFO_1001006","EFO_0002424","EFO_0004194","EFO_0000384","MONDO_0008315","EFO_0003060","EFO_0005221","EFO_0000537","HP_0100806","EFO_0003868","EFO_0003854","EFO_1001121","EFO_0001359","EFO_0000270","Orphanet_2781"],"count":42},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 4 approved and 30 investigational indications."}
{"id":"CHEMBL8659","canonicalSmiles":"CCCCCCCC/C=C\\CCCCCCCC(=O)O","inchiKey":"ZQPPMHVWECSIRJ-KTKRTIGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLEIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["18:1(N-9)","FEMA NO. 2815","NSC-9856","Oleic acid"],"crossReferences":{"PubChem":["144204637","144209165","144213641","17388831","26732603","26752911","75221"],"Wikipedia":["Oleic_acid"],"chEBI":["16196"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
